SHANGHAI, NANJING, China and SAN JOSE, Calif., March 28, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that the...
Hence then, the article about iaso bio announces approval of new drug application for equecabtagene autoleucel by the macau pharmaceutical administration bureau was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( IASO Bio Announces Approval of New Drug Application for Equecabtagene Autoleucel by the Macau Pharmaceutical Administration Bureau )
Also on site :
- Hollywood mourns loss of beloved makeup artist Jasen Kaplan
- My Husband Claimed He Was OK With My Extracurricular Sex Activities. My Biggest Mistake Was Believing Him.
- Suspected mountain lion attack in Colorado mountains under investigation